[{"Assets_0_Q1_USD":21195900000.0,"EarningsPerShareBasic_1_Q1_USD":3.47,"EarningsPerShareDiluted_1_Q1_USD":3.46,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":235200000.0,"NetIncomeLossConverted_1_Q1_USD":747500000.0,"RevenuesConverted_1_Q1_USD":2380100000.0,"StockholdersEquity_0_Q1_USD":11479000000.0,"StockholdersEquityConverted_0_Q1_USD":11467400000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":215900000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":215600000.0,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170425"}]